• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE AND ASSOCIATES, INC. HELEX ATRIAL SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE AND ASSOCIATES, INC. HELEX ATRIAL SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number HX1535
Device Problem Malposition of Device (2616)
Patient Problem Fainting (1847)
Event Date 11/25/2013
Event Type  malfunction  
Event Description
A little over six years ago, a 35mm helex atrial septal occluder was placed in a moderate 13mm secundum atrial septal defect.It appeared appropriately positioned but some movement of the right discs were later recorded but it appeared to be locked appropriately.Patient returned a few months ago because of near syncopal episodes.An echocardiogram demonstrated that the right atrial discs were abnormally positioned in the right atrium.A brain mri only demonstrated a subacute lacunar defect.A tee (transesophageal echo) demonstrated malposition of the right lower and upper discs.The right lower disc was apparently pushed up by flow from the inferior vena cava and the right upper disc pushed out by a 2.5cm thick lipomatous septum secundum.There was no evidence of residual atrial shunt by color flow or agitated contrast saline injections.Device fluoroscopy and chest ct confirmed the abnormal position of the right discs and the lipomatous atrial septum.There was not evidence of fracture of the disc wires and the right discs were appropriately locked by the locking mechanism.The left disc was appropriately positioned on the left side of the atrial septum.There was no apparent explanation for the abnormal position of the lower right atrial disc.A tilt test was normal and the patient had no further symptoms.She returned home with no further therapy to have continued observation and follow up in 6 months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HELEX ATRIAL SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W.L. GORE AND ASSOCIATES, INC.
1505 north fourth street
flagstaff AZ 86003
MDR Report Key3636404
MDR Text Key4178054
Report Number3636404
Device Sequence Number1
Product Code MLV
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Type of Report Initial
Report Date 12/03/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Invalid Data
Device Model NumberHX1535
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/17/2014
Device Age6 YR
Event Location Hospital
Date Report to Manufacturer02/20/2014
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-